NCT00366262View on ClinicalTrials.gov

Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2006

Study Completion Date

March 31, 2007

Conditions
Healthy
Interventions
DRUG

PLA-695

DRUG

Naproxen

DRUG

Placebo

Trial Locations (1)

77074

Houston

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00366262 - Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen | Biotech Hunter | Biotech Hunter